 |
On June 16, 2023, the "2023 Chinese Pharmaceutical CRO Enterprise Ranking" was released and grandly awarded at the "2023 Conference on High Quality De..
|
 |
On June 12, 2023, MindRank, which focuses on the use of AI to drive the development of new drugs, announced that the phase I clinical trial of its sel..
|
 |
Recently, the IND application of TollB-001 Tablets, a class 1.1 new drug for rheumatoid arthritis by Toll Biotech, has been officially approved by the..
|
 |
On June 12, 2023, the list of "18th China Listed Companies Competitive Credibility Company" organized by Chinese Securities Journal was announced.Shan..
|
 |
Recently, Shanghai Medicilon Inc. (Medicilon) and DP Technology Ltd. announced the signing of a strategic collaboration agreement. The two parties wil..
|
 |
The innovative ophthalmic drugs self-developed by Raymon Pharma have continuously achieved new breakthroughs, which is a strong evidence of the contin..
|
 |
Recently, Raymon Pharma announced that the clinical trial of self-developed RA1115-B1 eye drops for the treatment of neovascular (wet) age-related mac..
|
 |
Medicilon provides GLP-1 drug discovery, CMC research (API + formulation), pharmacodynamics research, PK study, GLP-1 safety evaluation and other serv..
|
 |
On May 25th, in recognition of the outstanding performance of Shanghai Medicilon Inc. in the development of new drugs, Dr. Yu Jiang, Dean of the Shang..
|
 |
Recently, the "3rd Pharmaceutical Innovation Award", a major award that has attracted the attention of pharmaceutical industry experts, academia, and ..
|
|
|
first
prev
Profile
Writing
Friends
Share This